IMNM - Immunome  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMNM is currently covered by 8 analysts with an average price target of $33.75. This is a potential upside of $11.74 (40.57%) from yesterday's end of day stock price of $24.01.

Immunome 's activity chart (see below) currently has 21 price targets and 34 ratings on display. The stock rating distribution of IMNM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.24% with an average time for these price targets to be met of 198.27 days.

Highest price target for IMNM is $40, Lowest price target is $26, average price target is $33.75.

Most recent stock forecast was given by from WEDBUSH on 12-Jun-2026. First documented stock forecast 27-Oct-2020.

Best performing analysts who are covering IMNM - Immunome :

Michael Schmidt Biren Amin Geulah Livshits Matthew Barcus Andres Maldonado

Currently out of the existing stock ratings of IMNM, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Dec-2023

$31

$11.04 (55.31%)

$31

27 days ago
(12-Jun-2026)

1/7 (14.29%)

$12.62 (68.66%)

20

Buy Since 08-Nov-2024

$30

$10.04 (50.30%)

$33

4 months 5 days ago
(04-Mar-2026)

0/4 (0%)

$7.48 (33.21%)

Buy Since 05-Sep-2025

$36

$16.04 (80.36%)

$33

4 months 5 days ago
(04-Mar-2026)

1/3 (33.33%)

$13.48 (59.86%)

150

Buy Since 12-Feb-2026

$40

$20.04 (100.40%)

4 months 27 days ago
(12-Feb-2026)

0/1 (0%)

$17.56 (78.25%)

Buy Since 02-Apr-2025

$32

$12.04 (60.32%)

$23

6 months 23 days ago
(16-Dec-2025)

1/2 (50%)

$8.52 (36.29%)

258

Show more analysts

Please expand the browser size to see the chart

What is IMNM (Immunome ) average time for price targets to be met?

On average it took 198.27 days on average for the stock forecasts to be realized with a an average price target met ratio 45.24

Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?

MICHAEL SCHMIDT

Which analyst has the most public recommendations on IMNM (Immunome )?

Michael Schmidt works at GUGGENHEIM and has 5 price targets and 6 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome )?

Cory Kasimov with highest potential upside - $20.04

Which analyst is the currently most reserved on IMNM (Immunome )?

Matthew Barcus with lowest potential downside - -$13.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?